Literature DB >> 26786161

Stable liver-specific expression of human IDOL in humanized mice raises plasma cholesterol.

Salam Ibrahim1, Suryanarayan Somanathan2, Jeffrey Billheimer3, James M Wilson2, Daniel J Rader3.   

Abstract

AIMS: IDOL (inducible degrader of the low-density lipoprotein receptor, LDLR) is an E3 ubiquitin ligase that promotes the ubiquitination and degradation of the LDLR. IDOL is a potential therapeutic target for the development of a novel class of low-density lipoprotein cholesterol (LDL-C)-lowering therapies. In an attempt to develop a mouse model for testing IDOL inhibitors, we examined the effects of adeno-associated virus (AAV)-mediated stable expression of human IDOL in the livers of mice 'humanized' with regard to lipoprotein metabolism. METHODS AND
RESULTS: Using a liver-specific AAV serotype 8 (AAV8)-mediated delivery, AAV-hIDOL produced a dose-dependent increase in LDL-C levels and a decrease in liver LDLR protein. Furthermore, we expressed hIDOL in a 'humanized' mouse model of heterozygous familial hypercholesterolaemia (LDLR(+/-)/Apobec1(-/-)/hApoB-Tg, LAhB). In this model, total cholesterol (TC) and LDL-C levels were increased by ∼60% starting from 1 week and were sustainable for at least 3 weeks post-injection. Finally, we demonstrate that the effects caused by hIDOL expression are LDLR- dependent given the unchanged plasma lipids in LAhB mice lacking LDLR.
CONCLUSION: In conclusion, our study demonstrates a dose-dependent physiological effect of human IDOL on LDL metabolism in mice. This provides a potential model for preclinical testing of IDOL inhibitors for reduction of LDL-C levels. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Hypercholesterolaemia; IDOL; LDLR; Lipoproteins; Therapeutic targets

Mesh:

Substances:

Year:  2016        PMID: 26786161      PMCID: PMC4798044          DOI: 10.1093/cvr/cvw010

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  16 in total

1.  AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia.

Authors:  Suryanarayan Somanathan; Frank Jacobs; Qiang Wang; Alexandra L Hanlon; James M Wilson; Daniel J Rader
Journal:  Circ Res       Date:  2014-07-14       Impact factor: 17.367

2.  The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans.

Authors:  Daphna Weissglas-Volkov; Anna C Calkin; Teresa Tusie-Luna; Janet S Sinsheimer; Noam Zelcer; Laura Riba; Ana Maria Vargas Tino; Maria Luisa Ordoñez-Sánchez; Ivette Cruz-Bautista; Carlos A Aguilar-Salinas; Peter Tontonoz; Päivi Pajukanta
Journal:  J Clin Invest       Date:  2011-07-18       Impact factor: 14.808

Review 3.  Plasma cholesteryl ester transfer protein.

Authors:  A R Tall
Journal:  J Lipid Res       Date:  1993-08       Impact factor: 5.922

Review 4.  Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms.

Authors:  T L Innerarity; J Borén; S Yamanaka; S O Olofsson
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

5.  Hepatic TRAP80 selectively regulates lipogenic activity of liver X receptor.

Authors:  Geun Hyang Kim; Gyun-Sik Oh; Jin Yoon; Gang Gu Lee; Ki-Up Lee; Seung-Whan Kim
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

6.  The LXR-Idol axis differentially regulates plasma LDL levels in primates and mice.

Authors:  Cynthia Hong; Stephanie M Marshall; Allison L McDaniel; Mark Graham; Joseph D Layne; Lei Cai; Elena Scotti; Rima Boyadjian; Jason Kim; Brian T Chamberlain; Rajendra K Tangirala; Michael E Jung; Loren Fong; Richard Lee; Stephen G Young; Ryan E Temel; Peter Tontonoz
Journal:  Cell Metab       Date:  2014-11-04       Impact factor: 27.287

7.  Identification of a loss-of-function inducible degrader of the low-density lipoprotein receptor variant in individuals with low circulating low-density lipoprotein.

Authors:  Vincenzo Sorrentino; Sigrid W Fouchier; Mohammad M Motazacker; Jessica K Nelson; Joep C Defesche; Geesje M Dallinga-Thie; John J P Kastelein; G Kees Hovingh; Noam Zelcer
Journal:  Eur Heart J       Date:  2013-01-16       Impact factor: 29.983

8.  Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia.

Authors:  Sadik H Kassim; Hui Li; Peter Bell; Suryanarayan Somanathan; William Lagor; Frank Jacobs; Jeffrey Billheimer; James M Wilson; Daniel J Rader
Journal:  Hum Gene Ther       Date:  2012-11-14       Impact factor: 5.695

9.  Genetic variants influencing circulating lipid levels and risk of coronary artery disease.

Authors:  Dawn M Waterworth; Sally L Ricketts; Kijoung Song; Li Chen; Jing Hua Zhao; Samuli Ripatti; Yurii S Aulchenko; Weihua Zhang; Xin Yuan; Noha Lim; Jian'an Luan; Sofie Ashford; Eleanor Wheeler; Elizabeth H Young; David Hadley; John R Thompson; Peter S Braund; Toby Johnson; Maksim Struchalin; Ida Surakka; Robert Luben; Kay-Tee Khaw; Sheila A Rodwell; Ruth J F Loos; S Matthijs Boekholdt; Michael Inouye; Panagiotis Deloukas; Paul Elliott; David Schlessinger; Serena Sanna; Angelo Scuteri; Anne Jackson; Karen L Mohlke; Jaako Tuomilehto; Robert Roberts; Alexandre Stewart; Y Antero Kesäniemi; Robert W Mahley; Scott M Grundy; Wendy McArdle; Lon Cardon; Gérard Waeber; Peter Vollenweider; John C Chambers; Michael Boehnke; Gonçalo R Abecasis; Veikko Salomaa; Marjo-Riitta Järvelin; Aimo Ruokonen; Inês Barroso; Stephen E Epstein; Hakon H Hakonarson; Daniel J Rader; Muredach P Reilly; Jacqueline C M Witteman; Alistair S Hall; Nilesh J Samani; David P Strachan; Philip Barter; Cornelia M van Duijn; Jaspal S Kooner; Leena Peltonen; Nicholas J Wareham; Ruth McPherson; Vincent Mooser; Manjinder S Sandhu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09-23       Impact factor: 8.311

10.  Discovery and refinement of loci associated with lipid levels.

Authors:  Cristen J Willer; Ellen M Schmidt; Sebanti Sengupta; Michael Boehnke; Panos Deloukas; Sekar Kathiresan; Karen L Mohlke; Erik Ingelsson; Gonçalo R Abecasis; Gina M Peloso; Stefan Gustafsson; Stavroula Kanoni; Andrea Ganna; Jin Chen; Martin L Buchkovich; Samia Mora; Jacques S Beckmann; Jennifer L Bragg-Gresham; Hsing-Yi Chang; Ayşe Demirkan; Heleen M Den Hertog; Ron Do; Louise A Donnelly; Georg B Ehret; Tõnu Esko; Mary F Feitosa; Teresa Ferreira; Krista Fischer; Pierre Fontanillas; Ross M Fraser; Daniel F Freitag; Deepti Gurdasani; Kauko Heikkilä; Elina Hyppönen; Aaron Isaacs; Anne U Jackson; Åsa Johansson; Toby Johnson; Marika Kaakinen; Johannes Kettunen; Marcus E Kleber; Xiaohui Li; Jian'an Luan; Leo-Pekka Lyytikäinen; Patrik K E Magnusson; Massimo Mangino; Evelin Mihailov; May E Montasser; Martina Müller-Nurasyid; Ilja M Nolte; Jeffrey R O'Connell; Cameron D Palmer; Markus Perola; Ann-Kristin Petersen; Serena Sanna; Richa Saxena; Susan K Service; Sonia Shah; Dmitry Shungin; Carlo Sidore; Ci Song; Rona J Strawbridge; Ida Surakka; Toshiko Tanaka; Tanya M Teslovich; Gudmar Thorleifsson; Evita G Van den Herik; Benjamin F Voight; Kelly A Volcik; Lindsay L Waite; Andrew Wong; Ying Wu; Weihua Zhang; Devin Absher; Gershim Asiki; Inês Barroso; Latonya F Been; Jennifer L Bolton; Lori L Bonnycastle; Paolo Brambilla; Mary S Burnett; Giancarlo Cesana; Maria Dimitriou; Alex S F Doney; Angela Döring; Paul Elliott; Stephen E Epstein; Gudmundur Ingi Eyjolfsson; Bruna Gigante; Mark O Goodarzi; Harald Grallert; Martha L Gravito; Christopher J Groves; Göran Hallmans; Anna-Liisa Hartikainen; Caroline Hayward; Dena Hernandez; Andrew A Hicks; Hilma Holm; Yi-Jen Hung; Thomas Illig; Michelle R Jones; Pontiano Kaleebu; John J P Kastelein; Kay-Tee Khaw; Eric Kim; Norman Klopp; Pirjo Komulainen; Meena Kumari; Claudia Langenberg; Terho Lehtimäki; Shih-Yi Lin; Jaana Lindström; Ruth J F Loos; François Mach; Wendy L McArdle; Christa Meisinger; Braxton D Mitchell; Gabrielle Müller; Ramaiah Nagaraja; Narisu Narisu; Tuomo V M Nieminen; Rebecca N Nsubuga; Isleifur Olafsson; Ken K Ong; Aarno Palotie; Theodore Papamarkou; Cristina Pomilla; Anneli Pouta; Daniel J Rader; Muredach P Reilly; Paul M Ridker; Fernando Rivadeneira; Igor Rudan; Aimo Ruokonen; Nilesh Samani; Hubert Scharnagl; Janet Seeley; Kaisa Silander; Alena Stančáková; Kathleen Stirrups; Amy J Swift; Laurence Tiret; Andre G Uitterlinden; L Joost van Pelt; Sailaja Vedantam; Nicholas Wainwright; Cisca Wijmenga; Sarah H Wild; Gonneke Willemsen; Tom Wilsgaard; James F Wilson; Elizabeth H Young; Jing Hua Zhao; Linda S Adair; Dominique Arveiler; Themistocles L Assimes; Stefania Bandinelli; Franklyn Bennett; Murielle Bochud; Bernhard O Boehm; Dorret I Boomsma; Ingrid B Borecki; Stefan R Bornstein; Pascal Bovet; Michel Burnier; Harry Campbell; Aravinda Chakravarti; John C Chambers; Yii-Der Ida Chen; Francis S Collins; Richard S Cooper; John Danesh; George Dedoussis; Ulf de Faire; Alan B Feranil; Jean Ferrières; Luigi Ferrucci; Nelson B Freimer; Christian Gieger; Leif C Groop; Vilmundur Gudnason; Ulf Gyllensten; Anders Hamsten; Tamara B Harris; Aroon Hingorani; Joel N Hirschhorn; Albert Hofman; G Kees Hovingh; Chao Agnes Hsiung; Steve E Humphries; Steven C Hunt; Kristian Hveem; Carlos Iribarren; Marjo-Riitta Järvelin; Antti Jula; Mika Kähönen; Jaakko Kaprio; Antero Kesäniemi; Mika Kivimaki; Jaspal S Kooner; Peter J Koudstaal; Ronald M Krauss; Diana Kuh; Johanna Kuusisto; Kirsten O Kyvik; Markku Laakso; Timo A Lakka; Lars Lind; Cecilia M Lindgren; Nicholas G Martin; Winfried März; Mark I McCarthy; Colin A McKenzie; Pierre Meneton; Andres Metspalu; Leena Moilanen; Andrew D Morris; Patricia B Munroe; Inger Njølstad; Nancy L Pedersen; Chris Power; Peter P Pramstaller; Jackie F Price; Bruce M Psaty; Thomas Quertermous; Rainer Rauramaa; Danish Saleheen; Veikko Salomaa; Dharambir K Sanghera; Jouko Saramies; Peter E H Schwarz; Wayne H-H Sheu; Alan R Shuldiner; Agneta Siegbahn; Tim D Spector; Kari Stefansson; David P Strachan; Bamidele O Tayo; Elena Tremoli; Jaakko Tuomilehto; Matti Uusitupa; Cornelia M van Duijn; Peter Vollenweider; Lars Wallentin; Nicholas J Wareham; John B Whitfield; Bruce H R Wolffenbuttel; Jose M Ordovas; Eric Boerwinkle; Colin N A Palmer; Unnur Thorsteinsdottir; Daniel I Chasman; Jerome I Rotter; Paul W Franks; Samuli Ripatti; L Adrienne Cupples; Manjinder S Sandhu; Stephen S Rich
Journal:  Nat Genet       Date:  2013-10-06       Impact factor: 38.330

View more
  8 in total

1.  A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.

Authors:  Sumeet A Khetarpal; Xuemei Zeng; John S Millar; Cecilia Vitali; Amritha Varshini Hanasoge Somasundara; Paolo Zanoni; James A Landro; Nicole Barucci; William J Zavadoski; Zhiyuan Sun; Hans de Haard; Ildikó V Toth; Gina M Peloso; Pradeep Natarajan; Marina Cuchel; Sissel Lund-Katz; Michael C Phillips; Alan R Tall; Sekar Kathiresan; Paul DaSilva-Jardine; Nathan A Yates; Daniel J Rader
Journal:  Nat Med       Date:  2017-08-21       Impact factor: 53.440

2.  An APOO Pseudogene on Chromosome 5q Is Associated With Low-Density Lipoprotein Cholesterol Levels.

Authors:  May E Montasser; Elizabeth A O'Hare; Xiaochun Wang; Alicia D Howard; Rebecca McFarland; James A Perry; Kathleen A Ryan; Kenneth Rice; Cashell E Jaquish; Alan R Shuldiner; Michael Miller; Braxton D Mitchell; Norann A Zaghloul; Yen-Pei C Chang
Journal:  Circulation       Date:  2018-09-25       Impact factor: 29.690

3.  Idol Depletion Protects against Spontaneous Atherosclerosis in a Hamster Model of Familial Hypercholesterolemia.

Authors:  Chenxi Liang; Xiaowei Wang; Kenan Peng; Pingping Lai; Ziwei Liu; Jiaao Ma; Xin Chen; Gang Liu; Mingqi Zheng; Yuhui Wang; Hongyuan Yang; George Liu; Xunde Xian; Mingming Gao
Journal:  Oxid Med Cell Longev       Date:  2022-05-24       Impact factor: 7.310

4.  A Novel Type 2 Diabetes Mouse Model of Combined Diabetic Kidney Disease and Atherosclerosis.

Authors:  Karin E Bornfeldt; Farah Kramer; Anna Batorsky; Jinkuk Choi; Kelly L Hudkins; Peter Tontonoz; Charles E Alpers; Jenny E Kanter
Journal:  Am J Pathol       Date:  2017-12-15       Impact factor: 4.307

Review 5.  Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management.

Authors:  Maria Mytilinaiou; Ioannis Kyrou; Mike Khan; Dimitris K Grammatopoulos; Harpal S Randeva
Journal:  Front Pharmacol       Date:  2018-07-12       Impact factor: 5.810

6.  MMAB promotes negative feedback control of cholesterol homeostasis.

Authors:  Leigh Goedeke; Alberto Canfrán-Duque; Noemi Rotllan; Balkrishna Chaube; Bonne M Thompson; Richard G Lee; Gary W Cline; Jeffrey G McDonald; Gerald I Shulman; Miguel A Lasunción; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  Nat Commun       Date:  2021-11-08       Impact factor: 14.919

Review 7.  The Progression of Treatment for Refractory Hypercholesterolemia: Focus on the Prospect of Gene Therapy.

Authors:  Zhi-Fan Li; Na-Qiong Wu
Journal:  Front Genet       Date:  2022-06-09       Impact factor: 4.772

8.  The Cholesterol-Modulating Effect of Methanol Extract of Pigeon Pea (Cajanus cajan (L.) Millsp.) Leaves on Regulating LDLR and PCSK9 Expression in HepG2 Cells.

Authors:  Heng-Yuan Chang; Jia-Ru Wu; Wan-Yun Gao; Huei-Ru Lin; Pei-Yi Chen; Chen-I Chen; Ming-Jiuan Wu; Jui-Hung Yen
Journal:  Molecules       Date:  2019-01-30       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.